Data Entry: Please note that the research database will be replaced by UNIverse by the end of October 2023. Please enter your data into the system https://universe-intern.unibas.ch. Thanks

Login for users with Unibas email account...

Login for registered users without Unibas email account...

 
"The NET Outcome": Are Neutrophil Extracellular Traps of Any Relevance to the Pathophysiology of Autoimmune Disorders in Childhood?
JournalItem (Reviews, Editorials, Rezensionen, Urteilsanmerkungen etc. in einer wissenschaftlichen Zeitschrift)
 
ID 4380650
Author(s) Giaglis, S.; Hahn, S.; Hasler, P.
Author(s) at UniBasel Hahn, Sinuhe
Year 2016
Title "The NET Outcome": Are Neutrophil Extracellular Traps of Any Relevance to the Pathophysiology of Autoimmune Disorders in Childhood?
Journal Front Pediatr
Volume 4
Pages 97
Keywords NETosis; NETs; Sle; biomarkers; juvenile idiopathic arthritis; neutrophils
Abstract Neutrophil extracellular trap (NET) formation represents a form of cell death distinct from apoptosis or necrosis, by which invading pathogens are simultaneously entangled and potentially eliminated. Increased NET formation is observed in systemic lupus erythematosus (SLE), rheumatoid arthritis, antineutrophil cytoplasmic antibody-associated small vessel vasculitis, antiphospholipid antibody syndrome (APS), and psoriasis. NETs contribute to the pathogenesis of autoimmunity by exposing cryptic autoepitopes, which may facilitate the generation of autoantibodies, induce the production of interferons, and activate the complement cascade. In SLE, augmented disease activity and renal disease are associated with increased NET formation, so that NETs could serve as a marker for the monitoring of disease activity. NETs can additionally cause endothelial cell damage and death and stimulate inflammation in atheromatous plaques, adding to the accelerated atherosclerosis witnessed in autoimmune disease. Since NETs induce production of interferons, assessing the extent of NET formation might facilitate the prediction of IFN-alpha levels and identification of SLE patients with presumably better responses to anti-IFN-alpha therapies or other novel therapeutic concepts, such as N-acetyl-cysteine and inhibitors of DNase 1 and peptidylarginine deiminase 4 (PAD4), which also target NETs. In summary, the study of NETs provides a novel approach to the understanding of autoimmune disease pathogenesis in childhood and opens new vistas in the development of sensitive disease markers and targeted therapies.
Publisher FRONTIERS MEDIA SA
ISSN/ISBN 2296-2360 (Print) 2296-2360 (Linking)
URL https://www.ncbi.nlm.nih.gov/pubmed/27679792
edoc-URL https://edoc.unibas.ch/61786/
Full Text on edoc No
Digital Object Identifier DOI 10.3389/fped.2016.00097
PubMed ID http://www.ncbi.nlm.nih.gov/pubmed/27679792
ISI-Number WOS:000383013300001
Document type (ISI) Article
 
   

MCSS v5.8 PRO. 0.519 sec, queries - 0.000 sec ©Universität Basel  |  Impressum   |    
25/04/2024